How Much Does Semaglutide Actually Cost in 2026?

Semaglutide is one of the most effective weight-loss drugs ever tested. It's also one of the most expensive — at least if you go the brand-name route. But in 2026, the price landscape has changed significantly. There are more options than ever, and some of them are genuinely affordable.

Here's what semaglutide actually costs right now, broken down by source.

The Brand-Name Price: Wegovy and Ozempic

Without insurance, Wegovy — the FDA-approved semaglutide for weight loss — runs about $1,350 per month. Ozempic, which is technically approved for type 2 diabetes but commonly prescribed off-label for weight loss, comes in at about $1,000 per month without coverage.

Those numbers stop most people cold. And they should. For most people without insurance, paying $1,000+ per month for a medication isn't realistic long-term.

The good news: you don't have to.

What Insurance Covers

Medicare now covers Wegovy for patients with cardiovascular disease — a major change that took effect in early 2026. For those patients, out-of-pocket costs under Medicare can drop to $35–$50 per month depending on the plan.

Private insurance is more inconsistent. Some plans cover Wegovy for obesity; many still don't. Ozempic gets better coverage because it's approved for diabetes. If you have a diabetes diagnosis alongside your weight concern, your insurance is more likely to cover it.

Best approach: call your insurance before assuming you're out of luck. Ask specifically about “semaglutide for weight management” and get the prior authorization requirements in writing.

Manufacturer Coupons and Savings Programs

Novo Nordisk runs two savings programs worth knowing about:

• Wegovy savings card — eligible commercially insured patients may pay as little as $0/month for the first few fills. Check Novo Nordisk's website for current terms.
• NovoCare patient assistance — for uninsured patients below certain income thresholds, Novo Nordisk provides free medication through your doctor's office.

These programs change. But if you're on commercial insurance and struggling with your copay, the Wegovy savings card is worth checking today.

TrumpRx: New Government Pricing

In early 2026, the Trump administration launched TrumpRx — a government-negotiated drug discount platform. Through participating pharmacies, uninsured patients can now access Wegovy for approximately $350 per month. That's a 70%+ reduction from retail.

TrumpRx doesn't sell medication directly. It connects you to pharmacies offering the negotiated price. You need a valid prescription but not insurance.

Oral Semaglutide: A New Option

In January 2026, the FDA approved the first oral GLP-1 pill — semaglutide in tablet form. Pricing runs $179–$299 per month depending on dose, available through Novo Nordisk's direct program and telehealth services like GoodRx Weight Loss.

The oral version requires daily dosing and early data suggests slightly less weight loss than the injectable. But for people who can't tolerate injections — or just don't want them — it's a real option now.

Telehealth Programs: Competitive Pricing Without the Pharmacy Hunt

Telehealth platforms offering FDA-approved semaglutide have become one of the most practical options for most people. You get the prescriber visit built in, the medication shipped to your door, and ongoing support — all in one monthly fee.

Prices vary by provider. Remedy Meds currently starts around $299/month for FDA-approved semaglutide, which is close to what compounded versions used to cost.

Compounded Semaglutide: The Budget Option That's Going Away

For two years, compounding pharmacies supplied semaglutide at $150–$300/month. That was only possible while the drug was on the FDA shortage list.

The shortage ended in February 2026. Compounders have 90 days to wind down. If you're currently on compounded semaglutide, your supply will likely stop or your price will rise significantly by mid-2026.

Some telehealth companies have already pivoted to FDA-approved products. Others haven't. Know which category your provider is in.

The Real Cost Comparison (2026)

What to Do Right Now

If you have insurance: call your plan. Ask specifically about semaglutide for weight management and what prior authorization requires.

If you don't have insurance: TrumpRx gets you brand-name Wegovy at ~$350. Telehealth programs like Remedy Meds offer the full service — prescriber plus medication — at competitive rates worth comparing.

If cost is the deciding factor: oral semaglutide at $179/month is the most affordable FDA-approved option available today.

One thing to avoid: staying on compounded semaglutide long-term. The supply is winding down, and by mid-2026 availability will be severely limited.

Will Prices Drop?

Eventually. Orforglipron, Eli Lilly's oral GLP-1 pill, is expected to launch mid-2026 at $149–$399/month. More competition means more pressure on Novo Nordisk's pricing.

But that's months away. If you need semaglutide now, use the options above.

Last updated: March 2026. Prices are approximate and subject to change.